|Articles|March 1, 2001

Pharmaceutical Executive

  • Pharmaceutical Executive-03-01-2001
  • Volume 0
  • Issue 0

Shortage: Vaccine Worries

United States-At this time last year, the United States} supply of tetanus vaccine was easily met by the two companies licensed to produce it there, Aventis Pasteur and Wyeth-Ayerst. But in June 2000, the latter ran into regulatory problems, and FDA seized thousands of substandard doses of acellular pertussis vaccine from the company}s Marietta, Pennsylvania, plant.

Articles in this issue

almost 25 years ago

Research: New Horizons

almost 25 years ago

Earnings: Tough Times Ahead

almost 25 years ago

Outbreak: Anthrax Alarm

almost 25 years ago

Patents: China on the Genome Map

almost 25 years ago

Privacy, Pediatrics, and Policy

almost 25 years ago

Lilly's International Family

almost 25 years ago

Update: Punishment and Reprieve

almost 25 years ago

Gateway to Japan

almost 25 years ago

Surrounded

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.